• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺乳头状癌中中期因子表达的免疫组织化学和原位杂交分析

Immunohistochemical and in situ hybridization analyses of midkine expression in thyroid papillary carcinoma.

作者信息

Kato M, Maeta H, Kato S, Shinozawa T, Terada T

机构信息

Second Department of Pathology, Faculty of Medicine, Tottori University, Yonago, Japan.

出版信息

Mod Pathol. 2000 Oct;13(10):1060-5. doi: 10.1038/modpathol.3880195.

DOI:10.1038/modpathol.3880195
PMID:11048798
Abstract

Midkine (MK) is a novel heparin-binding growth factor whose gene has been identified in embryonal carcinoma cells in early stages of retinoic acid-induced differentiation. We immunohistochemically examined 90 thyroid papillary carcinomas (85 invasive type and five encapsulated type), using a rat IgG2a monoclonal antibody against the carboxyl terminal region of human MK in archival paraffin sections. The thyroid tumors exhibited an intense reaction in the cytoplasm. Most of the papillary carcinomas (77/90), had tumor cells that expressed MK. These were classified into the following two types: invasive type (76/85) and encapsulated type (1/5). Notably, the intensity of MK was stronger at the invading border area of the tumors than in the center. In tissues adjacent to the cancer tissues, normal follicular epithelial cells expressed MK very faintly or not at all. The in situ hybridization analysis revealed that the signals of MK transcripts were found in the cytoplasm of the cancer cells. In the noncancerous follicular epithelial cells adjacent to neoplasm the signals of MK transcripts were detected very weakly or not at all. The distribution and localization of the MK-transcript signals determined by in situ hybridization analysis were similar to those obtained by immunohistochemical analysis. We conclude that thyroid papillary carcinoma strongly expresses MK protein and messenger RNA, and that this overexpression may relate to the development and invasion of these carcinomas.

摘要

中期因子(MK)是一种新型的肝素结合生长因子,其基因已在维甲酸诱导分化早期的胚胎癌细胞中被鉴定出来。我们使用针对人MK羧基末端区域的大鼠IgG2a单克隆抗体,对90例甲状腺乳头状癌(85例浸润型和5例包膜型)存档石蜡切片进行了免疫组织化学检查。甲状腺肿瘤在细胞质中呈现强烈反应。大多数乳头状癌(77/90)的肿瘤细胞表达MK。这些被分为以下两种类型:浸润型(76/85)和包膜型(1/5)。值得注意的是,肿瘤侵袭边缘区域的MK强度比中心更强。在癌组织相邻的组织中,正常滤泡上皮细胞非常微弱地表达MK或根本不表达。原位杂交分析显示,MK转录本信号存在于癌细胞的细胞质中。在肿瘤相邻的非癌性滤泡上皮细胞中,MK转录本信号检测非常微弱或根本未检测到。原位杂交分析确定的MK转录本信号的分布和定位与免疫组织化学分析获得的结果相似。我们得出结论,甲状腺乳头状癌强烈表达MK蛋白和信使RNA,这种过表达可能与这些癌症的发生和侵袭有关。

相似文献

1
Immunohistochemical and in situ hybridization analyses of midkine expression in thyroid papillary carcinoma.甲状腺乳头状癌中中期因子表达的免疫组织化学和原位杂交分析
Mod Pathol. 2000 Oct;13(10):1060-5. doi: 10.1038/modpathol.3880195.
2
Inverse correlation between heparan sulfate composition and heparanase-1 gene expression in thyroid papillary carcinomas: a potential role in tumor metastasis.甲状腺乳头状癌中硫酸乙酰肝素组成与乙酰肝素酶-1基因表达的负相关:在肿瘤转移中的潜在作用
Clin Cancer Res. 2003 Dec 1;9(16 Pt 1):5968-79.
3
Increased midkine expression in intrahepatic cholangiocarcinoma: immunohistochemical and in situ hybridization analyses.肝内胆管癌中中期因子表达增加:免疫组织化学和原位杂交分析
Liver. 2000 Jun;20(3):216-21. doi: 10.1034/j.1600-0676.2000.020003216.x.
4
Thyroid transcription factor-1 in normal, hyperplastic, and neoplastic follicular thyroid cells examined by immunohistochemistry and nonradioactive in situ hybridization.通过免疫组织化学和非放射性原位杂交检测正常、增生性和肿瘤性甲状腺滤泡细胞中的甲状腺转录因子-1。
Mod Pathol. 2000 May;13(5):570-6. doi: 10.1038/modpathol.3880098.
5
In situ detection of hTERT mRNA relates to Ki-67 labeling index in papillary thyroid carcinoma.甲状腺乳头状癌中hTERT mRNA的原位检测与Ki-67标记指数相关。
J Surg Res. 2001 Jul;99(1):75-83. doi: 10.1006/jsre.2001.6124.
6
Immunohistochemical study of type-1 blood antigen expressions in thyroid tumors: the significance for papillary carcinomas.甲状腺肿瘤中1型血型抗原表达的免疫组织化学研究:对乳头状癌的意义
Mod Pathol. 2000 Jul;13(7):736-41. doi: 10.1038/modpathol.3880127.
7
Heterogeneous distribution of thyrotrophin receptor messenger ribonucleic acid (TSH-R mRNA) in papillary thyroid carcinomas detected by in situ hybridization.通过原位杂交检测甲状腺乳头状癌中促甲状腺激素受体信使核糖核酸(TSH-R mRNA)的异质性分布。
Clin Endocrinol (Oxf). 1996 Mar;44(3):259-67.
8
Expression of the melanoma-associated antigen is associated with progression of human thyroid cancer.黑色素瘤相关抗原的表达与人类甲状腺癌的进展相关。
Endocr Relat Cancer. 2009 Jun;16(2):455-66. doi: 10.1677/ERC-09-0002. Epub 2009 Mar 4.
9
Increased midkine expression in hepatocellular carcinoma.肝细胞癌中中期因子表达增加。
Arch Pathol Lab Med. 2000 Jun;124(6):848-52. doi: 10.5858/2000-124-0848-IMEIHC.
10
Apolipoprotein e expression in anaplastic thyroid carcinoma.载脂蛋白e在间变性甲状腺癌中的表达。
Oncology. 2006;71(5-6):388-93. doi: 10.1159/000107112. Epub 2007 Aug 9.

引用本文的文献

1
Adenovirus as a Vector and Oncolytic Virus.腺病毒作为载体和溶瘤病毒
Curr Issues Mol Biol. 2023 Jun 2;45(6):4826-4840. doi: 10.3390/cimb45060307.
2
Diagnostic performance of Midkine ratios in fine-needle aspirates for evaluation of Cytologically indeterminate thyroid nodules.细针抽吸物中中期因子比值对细胞学不确定甲状腺结节评估的诊断性能。
Diagn Pathol. 2021 Oct 25;16(1):92. doi: 10.1186/s13000-021-01150-y.
3
Analysis of genetic information from the antlers of Rangifer tarandus (reindeer) at the rapid growth stage.分析处于快速生长阶段的驯鹿(Rangifer tarandus)鹿角的遗传信息。
PLoS One. 2020 Mar 13;15(3):e0230168. doi: 10.1371/journal.pone.0230168. eCollection 2020.
4
Changes of serum midkine as a dynamic prognostic factor to monitor disease status in papillary thyroid cancer.血清中期因子作为动态预后因素在监测甲状腺乳头状癌疾病状态中的变化
Medicine (Baltimore). 2018 Sep;97(36):e12242. doi: 10.1097/MD.0000000000012242.
5
Abnormalities in alternative splicing of angiogenesis-related genes and their role in HIV-related cancers.血管生成相关基因的可变剪接异常及其在HIV相关癌症中的作用。
HIV AIDS (Auckl). 2017 Mar 30;9:77-93. doi: 10.2147/HIV.S124911. eCollection 2017.
6
Serum midkine as a surrogate biomarker for metastatic prediction in differentiated thyroid cancer patients with positive thyroglobulin antibody.血清中期因子作为甲状腺球蛋白抗体阳性分化型甲状腺癌患者转移预测的替代生物标志物。
Sci Rep. 2017 Feb 27;7:43516. doi: 10.1038/srep43516.
7
Midkine: A Novel Biomarker to Predict Malignancy in Patients with Nodular Thyroid Disease.中期因子:一种预测结节性甲状腺疾病患者恶性肿瘤的新型生物标志物。
Int J Endocrinol. 2016;2016:6035024. doi: 10.1155/2016/6035024. Epub 2016 Jun 30.
8
The clinical and prognostic significance of midkine in breast cancer patients.中期因子在乳腺癌患者中的临床及预后意义。
Tumour Biol. 2015 Dec;36(12):9789-94. doi: 10.1007/s13277-015-3710-x. Epub 2015 Jul 10.
9
Midkine concentrations in fine-needle aspiration of benign and malignant thyroid nodules.良性和恶性甲状腺结节细针穿刺中的中期因子浓度。
Clin Endocrinol (Oxf). 2015 Dec;83(6):977-84. doi: 10.1111/cen.12676. Epub 2015 Jan 15.
10
Midkine: a novel prognostic biomarker for cancer.中期因子:癌症的一种新型预后生物标志物。
Cancers (Basel). 2010 Apr 20;2(2):624-41. doi: 10.3390/cancers2020624.